Mensinger Mike bought BBNX
January 31, 2025 · Form 4 insider transaction
Mensinger Mike bought 15,107 shares of Beta Bionics, Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
15,107
Price
N/A
Total value
N/A
InsiderMensinger Mike
RoleOfficer
CompanyBeta Bionics, Inc. (BBNX)
SecurityCommon Stock
Transaction codeC: Conversion of a derivative
Transaction dateJanuary 31, 2025
Filing dateFebruary 3, 2025
Shares owned after15,107
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Immediately prior to the closing of the initial public offering, each share of Series D Preferred Stock (the "Preferred Stock") was converted into an equal number of shares of Class B Common Stock and subsequently was converted into an equal number of shares of Common Stock without payment of further consideration. The Preferred Stock had no expiration date.